SHLISSEL BRIAN S
Transaction: 02/27/2026
BUY
Change
+400
Price
$9.37
Filing
02/27/2026
Type
BUY
Allspring Multi-Sector Income Fund
ERC • Asset Management - Income
$9.18
▼ -0.02 (-0.22%)
Current price
EarningsLatest report: Oct 31, 2025
FAVORABLE PROFILEAttractiveConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Strong business quality with supportive growth and cash-flow evidence. Valuation still matters, but the historical ratio profile is favorable.
Market Cap
$257.53M
Growth
-6.2%
Cash Flow
5/5
Trend
Stable
Evidence
Stable or improving margins · 102.9%Positive free cash flow · 0.87Consistent free cash flow · 5/5Reasonable earnings multiple · 9.78Manageable debt level · 0.42
Financial data as of: Oct 31, 2025, 12:00 AM UTCLast earnings update: Oct 31, 2025, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$9.18
Change-0.22%
Shares Out28.05M
Market Cap$257.53M
Enterprise Value$366.64M
52W Range8.72 - 9.78
Beta0.55
P/E3.96
P/S5.09
P/B0.91
P/FCF6.35
EV/Sales7.25
Price$9.18
Change-0.22%
Shares Out28.05M
Market Cap$257.53M
Enterprise Value$366.64M
52W Range8.72 - 9.78
Beta0.55
P/E3.96
P/S5.09
P/B0.91
P/FCF6.35
EV/Sales7.25
EV/EBITDA4.67
EV/FCF9.05
Earnings Yield25.25%
FCF Yield15.74%
Dividend Yield17.90%
Gross Margin90.17%
Oper. Margin126.17%
Profit Margin102.94%
Debt/Eq0.42
Current Ratio1.53
Quick Ratio1.53
Revenue 5Y-6.19%
FCF 5Y-2.46%
Volume78.55K
Avg Volume72.19K
Investment DNA
How strong this company looks for long-term investors
72
out of 100
Business Quality
Margins, moat, returns
90/100
Financial Strength
Debt, cash, stability
81/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
72/100
Why this score▼
Stable or improving margins · 102.9%Positive free cash flow · 0.87Consistent free cash flow · 5/5Reasonable earnings multiple · 9.78Manageable debt level · 0.42Healthy liquidity · 1.53
Analyst view
No analyst data available now.
Insider Transactions
Recent executive and insider activity
SHLISSEL BRIAN S
Transaction: 01/02/2026
OTHER
Change
0
Price
Not reported
Filing
01/02/2026
Type
OTHER
Miller Cindy J
Transaction: 01/02/2026
OTHER
Change
0
Price
Not reported
Filing
01/02/2026
Type
OTHER
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| SHLISSEL BRIAN S | BUY | +400 | $9.37 | 02/27/2026 | 02/27/2026 |
| SHLISSEL BRIAN S | OTHER | 0 | Not reported | 01/02/2026 | 01/02/2026 |
| Miller Cindy J | OTHER | 0 | Not reported | 01/02/2026 | 01/02/2026 |
| Reed Andrew Michael | OTHER | 0 | Not reported | 08/07/2025 | 08/07/2025 |
| Barbieri Thomas Edward | OTHER | 0 | Not reported | 03/18/2025 | 03/18/2025 |
| Tran Jimmy T | OTHER | 0 | Not reported | 03/13/2025 | 03/13/2025 |
| Kenney John | OTHER | 0 | Not reported | 01/07/2025 | 01/07/2025 |
| Hicks Adam F.S. | OTHER | 0 | Not reported | 11/04/2024 | 11/04/2024 |
| Ebsworth William R. | SELL | -1,500 | $9.49 | 01/09/2024 | 01/09/2024 |
| POLISSON JAMES | SELL | -1,000 | $9.41 | 01/04/2024 | 01/04/2024 |
| Ebsworth William R. | BUY | +1,700 | $8.84 | 06/01/2023 | 06/02/2023 |
| POLISSON JAMES | BUY | +1,000 | $8.82 | 06/01/2023 | 06/02/2023 |
| Crawford Jonathan | OTHER | 0 | Not reported | 04/17/2023 | 04/17/2023 |
| Grunberg Jennifer Lea | OTHER | 0 | Not reported | 04/17/2023 | 04/17/2023 |
| Felsch Paul Werner | OTHER | 0 | Not reported | 02/08/2023 | 02/08/2023 |
| FREEMAN JANE A | BUY | +150 | $9.75 | 08/22/2022 | 08/29/2022 |
| Baker Christopher Micah | OTHER | 0 | Not reported | 01/12/2022 | 01/12/2022 |
| Brotman Karin | OTHER | 0 | Not reported | 12/07/2021 | 12/07/2021 |
| McKinley Kate Sandman | OTHER | 0 | Not reported | 11/09/2021 | 11/09/2021 |
| Prasse Richard Matthew | OTHER | 0 | Not reported | 10/18/2021 | 10/18/2021 |